FDA Adverse Event Injury Summary report: N

AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM

MDR report key: 974076 · Received January 2, 2008

Report

Report Number
1018233-2007-00092
Event Type
Injury
Date Received
January 2, 2008
Report Date
January 2, 2008
Manufacturer
C.R. BARD, INC.
Product Code
FTL
PMA / PMN Number
K063712
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NV, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE LOT NUMBER IS UNK; THEREFORE, NO REVIEW OF THE DEVICE HISTORY RECORD COULD BE PERFORMED. INFECTION IS A WELL KNOWN POTENTIAL COMPLICATION OF THIS TYPE OF PROCEDURE. THE IFU WHICH ACCOMPANIES EACH DEVICE STATES PROCEDURE. THE IFU WHICH ACCOMPANIES EACH DEVICE STATES IN THE SECTION LABELED: ADVERSE REACTIONS- THAT POTENTIAL ADVERSE REACTIONS ARE THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS, INCLUDING HEMATOMA, SEROMA, MUCOSAL OR VISCERAL EROSION, INFECTION, INFLAMMATION, SENSITIZATION, DYSPAREUNIA, SCARIFICATION AND CONTRACTION, FISTULA FORMATION, EXTRUSION AND RECURRENCE OF VAGINAL WALL PROLAPSE. PERFORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER, BOWEL, RECTUM, OR ANY VISCERA MAY OCCUR DURING NEEDLE PASSAGE. THE PRODUCT IS RECOMMENDED TO ONLY BE USED BY PHYSICIANS WHO ARE TRAINED IN SURGICAL PROCEDURES AND TECHNIQUES REQUIRED FOR PELVIC FLOOR RECONSTRUCTION AND THE IMPLANTATION OF NONABSORBABLE MESHES. BASELINE REPORT PREVIOUSLY FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT APPROX. 4-6 WEEKS FOLLOWING A POSTERIOR PROCEDURE, THE PT DEVELOPED GLUTEAL ABSCESSES. THE PT WAS DESCRIBED AS DOING VERY WELL UNTIL THEN. THE DOCTOR STATED THAT THE ABSCESS SEEMS TO BE RUNNING FROM BENEATH THE PERI-ANAL SKIN INCISION, UP ALONG THE DISTAL TRACT. THE PT WAS PLACED ON KEFLEX AND FLAGYL. THE PT WILL BE EXAMINED IN 2007. ADD'L INFO HAS BEEN REQUESTED BUT NOT YET RECEIVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM FTL C.R. BARD, INC. NA UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK YR Required Intervention